000 01785 a2200529 4500
005 20250513030531.0
264 0 _c19960117
008 199601s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(95)02021-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aParsons, M E
245 0 0 _aProperties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties.
_h[electronic resource]
260 _bBiochemical pharmacology
_cNov 1995
300 _a1551-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAminoquinolines
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntacids
_xpharmacology
650 0 4 _aBinding, Competitive
650 0 4 _aDogs
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGastric Acid
_xmetabolism
650 0 4 _aGastric Fistula
_xphysiopathology
650 0 4 _aGastric Juice
_xdrug effects
650 0 4 _aGastric Mucosa
_xdrug effects
650 0 4 _aHistamine Antagonists
_xpharmacology
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aMale
650 0 4 _aOmeprazole
_xpharmacology
650 0 4 _aPotassium
_xmetabolism
650 0 4 _aProton Pump Inhibitors
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSecretory Rate
_xdrug effects
650 0 4 _aStomach
_xenzymology
700 1 _aRushant, B
700 1 _aRasmussen, T C
700 1 _aLeach, C
700 1 _aIfe, R J
700 1 _aPostius, S
700 1 _aPope, A J
773 0 _tBiochemical pharmacology
_gvol. 50
_gno. 10
_gp. 1551-6
856 4 0 _uhttps://doi.org/10.1016/0006-2952(95)02021-7
_zAvailable from publisher's website
999 _c7503223
_d7503223